[go: up one dir, main page]

AR019409A1 - Derivados de ftalacina utiles como inhibidores de la fosfodiestearasa 4 y composiciones farmaceuticas que incluyen dichos derivados - Google Patents

Derivados de ftalacina utiles como inhibidores de la fosfodiestearasa 4 y composiciones farmaceuticas que incluyen dichos derivados

Info

Publication number
AR019409A1
AR019409A1 ARP990103501A ARP990103501A AR019409A1 AR 019409 A1 AR019409 A1 AR 019409A1 AR P990103501 A ARP990103501 A AR P990103501A AR P990103501 A ARP990103501 A AR P990103501A AR 019409 A1 AR019409 A1 AR 019409A1
Authority
AR
Argentina
Prior art keywords
alkyl
heterocycle
aryl
optionally substituted
alkoxy
Prior art date
Application number
ARP990103501A
Other languages
English (en)
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Publication of AR019409A1 publication Critical patent/AR019409A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/42—Radicals substituted by singly-bound nitrogen atoms having hetero atoms attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C07D237/34—Phthalazines with nitrogen atoms directly attached to carbon atoms of the nitrogen-containing ring, e.g. hydrazine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Macromonomer-Based Addition Polymer (AREA)

Abstract

Compuestos con formula (1) donde: la línea punteada es un enlace simple o doble; Z es NH, metileno, una cadena alquilénica C2-6 opcionalmente ramificaday/o insaturada y/o interrumpida por un residuo cicloalquilo C5-7; A es fenilo o heterociclo opcionalmente sustituido por uno o más sustituyentes seleccionadosentre grupos oxo, nitro, carboxi o átomos de halogeno, o un grupo COR4 donde R4 es hidroxi, alcoxi C1-6, amino opcionalmente sustituido por uno o dos gruposalquilo C1-6 o por hidroxi; R es un grupo alquilo C1-6 o polifluor-alquilo C1-6; R1 está ausente cuando la línea punteada es un enlace doble, o cuando la líneapunteada es un enlace simple, es (a) hidrogeno; (b) alquilo C1-6 opcionalmente sustituido por arilo, por heterociclo o por ungrupo COR5 donde R5 es hidroxi,alcoxi C1-4 o hidroxiamino; (c) -COR6 donde R6 es hidrogeno, arilo, aril-alquilo C1-6, amino opcionalmente alquilado o monohidroxilato, hidroxi, alcoxi C1-4,carboxi, alcoxicarbonilo C1-4, HN=C(NH2)-, o alquilo C1-4 opcionalmente sustituido por heterociclo; (d) alquilosulfonil C1-4; R2 representa dos átomos dehidrogeno o un grupo =O cuando la línea punteada es un enlace simple, o, cuando la línea punteada es un enlace doble, R2 es hidrogeno, ciano, alcoxicarboniloC1-4, amido, opcionalmente sustituido por arilo o heterociclo, alquilo C1-8, alquenilo C2-8 o alquinilo C2-8 opcionalmente ramificado y/o sustituido por ariloo heterociclo; ariloxi, heterocicliloxi, aril-alcoxi C1-4, heterociclil-alcoxi C1-4, amino sustituido por uno o dos grupos alquilo C1-4, arilamino,heterociclilamino, aril-alquiloamino C1-4, heterociclil-alquiloamino C1-4; R3 es hidrogeno, o un alquilo C1-8, alquenilo C2-8 o alquinilo C2-8 grupoopcionalmente sustituido por hidroxi, oxo, ariloo heterociclo, y opcionalmente interrumpido por uno o más heteroátomos o heterogrupos; los derivados N->O delos compuestos con formula (I) y sus sales farmacéuticamente aceptables son inhibidores de la PDE 4.
ARP990103501A 1998-07-21 1999-07-16 Derivados de ftalacina utiles como inhibidores de la fosfodiestearasa 4 y composiciones farmaceuticas que incluyen dichos derivados AR019409A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT98MI001670A ITMI981670A1 (it) 1998-07-21 1998-07-21 Derivati ftalazinici inibitori della fosfodiesterasi 4

Publications (1)

Publication Number Publication Date
AR019409A1 true AR019409A1 (es) 2002-02-20

Family

ID=11380474

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990103501A AR019409A1 (es) 1998-07-21 1999-07-16 Derivados de ftalacina utiles como inhibidores de la fosfodiestearasa 4 y composiciones farmaceuticas que incluyen dichos derivados

Country Status (35)

Country Link
US (2) US6329370B1 (es)
EP (2) EP1097142B1 (es)
JP (1) JP2002521370A (es)
KR (1) KR20010087161A (es)
CN (1) CN1127486C (es)
AP (1) AP2000001993A0 (es)
AR (1) AR019409A1 (es)
AT (1) ATE279397T1 (es)
AU (1) AU765457B2 (es)
BG (1) BG105063A (es)
BR (1) BR9911175A (es)
CA (1) CA2338044A1 (es)
CO (1) CO5090842A1 (es)
DE (1) DE69921139T2 (es)
EA (1) EA200100062A1 (es)
EE (1) EE200100039A (es)
HK (1) HK1039124B (es)
HR (1) HRP20010057A2 (es)
HU (1) HUP0102646A3 (es)
ID (1) ID28874A (es)
IL (1) IL139490A0 (es)
IS (1) IS5772A (es)
IT (1) ITMI981670A1 (es)
MX (1) MXPA01000670A (es)
NO (1) NO318988B1 (es)
NZ (1) NZ507926A (es)
OA (1) OA11582A (es)
PA (1) PA8478301A1 (es)
PE (1) PE20000755A1 (es)
PL (1) PL345187A1 (es)
SK (1) SK1002001A3 (es)
TW (1) TW509682B (es)
UA (1) UA68383C2 (es)
WO (1) WO2000005218A1 (es)
YU (1) YU77500A (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO4950519A1 (es) * 1997-02-13 2000-09-01 Novartis Ag Ftalazinas, preparaciones farmaceuticas que las comprenden y proceso para su preparacion
IT1296984B1 (it) * 1997-12-19 1999-08-03 Zambon Spa Derivati ftalazinici inibitori della fosfodiesterasi 4
ITMI981671A1 (it) 1998-07-21 2000-01-21 Zambon Spa Derivati ftalazinici inibitori della fosfodisterasi 4
DE19921567A1 (de) 1999-05-11 2000-11-16 Basf Ag Verwendung von Phthalazine-Derivaten
DE19963607B4 (de) * 1999-12-23 2005-12-15 Schering Ag Verfahren zur Herstellung von 4-(Heteroaryl-methyl) halogen-1(2H)-phthalazinonen
ITMI20000261A1 (it) 2000-02-16 2001-08-16 Zambon Group Processo per la preparazione di piridiniliden-ftalidi
US6703390B2 (en) * 2000-04-13 2004-03-09 Transgenomic, Inc. Sulfur containing dihydrophthalazine antagonists of excitatory amino acid receptors
US6525049B2 (en) * 2000-07-05 2003-02-25 Pharmacia & Upjohn Company Pyrroloquinolones as antiviral agents
WO2002044157A2 (en) * 2000-12-01 2002-06-06 Iconix Pharmaceuticals, Inc. Parb inhibitors
ITMI20022739A1 (it) * 2002-12-23 2004-06-24 Zambon Spa Derivati ftalazinici inibitori della fosfodiesterasi 4.
ITMI20022738A1 (it) * 2002-12-23 2004-06-24 Zambon Spa Derivati ftalazinici inibitori della fosfodiesterasi 4.
US7652036B2 (en) 2003-02-25 2010-01-26 Topotarget Uk Limited Carbamic acid compounds comprising a bicyclic heteroaryl group as HDAC inhibitors
ITMI20031451A1 (it) * 2003-07-16 2005-01-17 Zambon Spa Derivati diidro-ftalazinici inibitori della fosfodiesterasi 4
CN1984904A (zh) * 2004-05-08 2007-06-20 神经能质公司 3－芳基－5,6－二取代哒嗪
CA2593005A1 (en) * 2005-01-03 2006-07-13 Myriad Genetics Inc. Pharmaceutical compounds as activators of caspases and inducers of apoptosis and the use thereof
BRPI0617674A2 (pt) 2005-10-19 2011-08-02 Ranbaxy Lab Ltd composições farmacêuticas e seus usos
WO2008061108A2 (en) 2006-11-15 2008-05-22 Forest Laboratories Holdings Limited Phthalazine derivatives
CA2733128C (en) * 2008-08-13 2016-05-24 Boehringer Ingelheim International Gmbh Phthalazinone compounds as chymase inhibitors
CN102108078B (zh) * 2009-12-24 2013-10-30 沈阳药科大学 1,4-取代酞嗪类化合物及其制备方法和用途
KR20140090665A (ko) * 2011-11-09 2014-07-17 아비에 도이치란트 게엠베하 운트 콤파니 카게 포스포디에스테라제 타입 １０ａ의 억제제로서 유용한 헤테로사이클릭 카복스아미드

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2063249A (en) * 1979-10-09 1981-06-03 Mitsubishi Yuka Pharma 4-Phenylphthalazine derivatives
JPH03106873A (ja) * 1989-09-20 1991-05-07 Morishita Pharmaceut Co Ltd １―ピリジルフタラジン誘導体及びそれらを含有する血小板凝集抑制剤
ES2068413T3 (es) * 1990-03-30 1995-04-16 Mitsubishi Chem Ind Derivados de 4-fenilftalazina.
EP0634404A1 (en) * 1993-07-13 1995-01-18 Rhone Poulenc Agriculture Ltd. Phtalazin derivatives and their use as pesticides
DE69533057T2 (de) * 1994-08-09 2005-06-16 Eisai Co., Ltd. Kondensierte pyridazinverbindungen
IT1296984B1 (it) * 1997-12-19 1999-08-03 Zambon Spa Derivati ftalazinici inibitori della fosfodiesterasi 4

Also Published As

Publication number Publication date
IL139490A0 (en) 2001-11-25
PL345187A1 (en) 2001-12-03
NO20010331L (no) 2001-03-20
HK1039124B (zh) 2005-04-01
EA200100062A1 (ru) 2001-08-27
BR9911175A (pt) 2001-03-20
JP2002521370A (ja) 2002-07-16
TW509682B (en) 2002-11-11
HUP0102646A3 (en) 2003-01-28
BG105063A (en) 2001-07-31
AP2000001993A0 (en) 2000-12-31
HK1039124A1 (en) 2002-04-12
CA2338044A1 (en) 2000-02-03
DE69921139T2 (de) 2005-10-13
US6492360B1 (en) 2002-12-10
NZ507926A (en) 2002-10-25
OA11582A (en) 2004-07-26
MXPA01000670A (es) 2002-05-14
ID28874A (id) 2001-07-12
ITMI981670A1 (it) 2000-01-21
CN1127486C (zh) 2003-11-12
DE69921139D1 (de) 2004-11-18
HUP0102646A2 (hu) 2001-12-28
ITMI981670A0 (it) 1998-07-21
AU765457B2 (en) 2003-09-18
US6329370B1 (en) 2001-12-11
PA8478301A1 (es) 2000-09-29
AU5281099A (en) 2000-02-14
CO5090842A1 (es) 2001-10-30
WO2000005218A1 (en) 2000-02-03
EP1097142A1 (en) 2001-05-09
PE20000755A1 (es) 2000-09-01
EP1097142B1 (en) 2004-10-13
EP1371648A1 (en) 2003-12-17
ATE279397T1 (de) 2004-10-15
YU77500A (sh) 2002-11-15
NO318988B1 (no) 2005-05-30
SK1002001A3 (en) 2001-12-03
IS5772A (is) 2000-12-15
KR20010087161A (ko) 2001-09-15
UA68383C2 (en) 2004-08-16
NO20010331D0 (no) 2001-01-19
HRP20010057A2 (en) 2002-04-30
CN1305467A (zh) 2001-07-25
EE200100039A (et) 2002-06-17

Similar Documents

Publication Publication Date Title
AR019409A1 (es) Derivados de ftalacina utiles como inhibidores de la fosfodiestearasa 4 y composiciones farmaceuticas que incluyen dichos derivados
EA200100061A1 (ru) Производные фталазина в качестве ингибиторов фосфодиэстеразы 4
AR071739A1 (es) Inhibidores de transcriptasa reversa
PE20030969A1 (es) Compuestos heterociclicos, activos inhibidores de beta-lactamasas
CO5600998A2 (es) Fluoropirrolidinas como inhibidores de dipeptidil peptidasa
AR055053A1 (es) Compuestos indol sustituidos con actividad inhibidora de nos. composiciones farmaceuticas.
MX9202142A (es) Nuevos derivados de urea, proceso para su preparacion, y composicion farmaceutica que los comprende.
AR072166A1 (es) Derivado de piperidina y su uso como inhibidor de renina superior
RU2010121763A (ru) Производные пиридазинона и ингибиторы р2х7 рецептора
CY1107677T1 (el) Παραγωγα της 1-[indol-3-yl)carbonyl]piperazine
AR033379A1 (es) Compuestos de difenilurea, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
AR018915A1 (es) Inhibidores de proteasas diacilhidrazinicos, composicion farmaceutica que la comprenden, usos de los mismos para la manufactura de un medicamento, unprocedimiento de fabricacion de dichos compuestos
HUP0302770A2 (hu) Tripeptidil peptidáz inhibitorok, eljárás az előállítására és ezeket tartalmazó gyógyszerkészítmények
MEP22508A (en) Novel 1,2,3-substituted indolizine derivatives, inhibitors of fgfs, method for making same and pharmaceutical compositions containing same
ES2195382T3 (es) Compuestos indolcarboxilicos y su uso como compuestos farmaceuticos.
CO4910149A1 (es) Compuestos de 2-imidazolinilaminoindol utiles como agonistas de alfa-2 adrenoceptores
EA199901102A1 (ru) Производные азетидинилпропилпиперидина, промежуточные соединения и применение в качестве антагонистов тахикинина
TR200000725T2 (tr) Bir monoamin oksidaz inhibitörü ve h5-HT1B antagonistinin bileşimi
DK0888313T3 (da) 2,3-benzodiazepinderivater og deres anvendelse af AMPA-receptorhæmmere
AR034206A1 (es) Un procedimiento para la preparacion de mesilatos de derivados de piperazina y dichos mesilatos
CO5540311A2 (es) Derivados de pirimidina utiles como inhibidores de cox-2 selectivos
AR016501A1 (es) Compuestos inhibidores de las fkbp, composiciones farmaceuticas, uso para la preparacion de medicamentos y procesos de preparacion e intermediarios.
NO995289D0 (no) Benzimidazol-derivater
ES2055651A1 (es) Procedimiento para la obtencion de nuevas amidinas derivadas de 3-aminoetilindoles.
CO4980875A1 (es) Nuevos derivados de la equinocandina, su procedimiento de preparacion y su aplicacion como fungicidas

Legal Events

Date Code Title Description
FB Suspension of granting procedure